Business Standard

Single-dose Sputnik Light shows 70% efficacy against Delta variant

RDIF says Sputnik Light can act as a booster shot for even those who have been vaccinated with other vaccines like mRNA candidates

Sputnik
Premium

Sohini Das Mumbai
The Russian Direct Investment Fund (RDIF) claimed that its Covid-19 vaccine Sputnik Light, a single dose shot or the first dose component of Sputnik V vaccine shows 70 per cent efficacy against the Delta variant of the Sars-CoV-2 virus. In people under 60 years, the vaccine is even more effective at 75 per cent, the RDIF said.

The developer of the vaccine, Gamaleya Center, has submitted an article analysing Sputnik Light's efficacy against the Delta variant, to the medRxiv preprint server for health sciences for publication this week.

Speaking to the media from Moscow, Kirill Dimitriev, CEO, RDIF, said, “Sputnik

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 13 2021 | 7:12 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com